STOCK TITAN

Insider David Watson plans 7,832-share APLS (NASDAQ: APLS) sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An individual holder of APLS common stock has filed a Rule 144 notice to sell 7,832 shares. The planned sale is to be executed through Fidelity Brokerage Services LLC on or about 01/22/2026 on the NASDAQ, with an indicated aggregate market value of $170,466.61. The filing notes that 126,525,218 shares of this class were outstanding.

The shares to be sold were acquired on 01/21/2026 via restricted stock vesting from the issuer as compensation, in the same amount of 7,832 shares. The notice also lists prior sales of APLS common stock by David O. Watson over the past three months, including transactions on 11/17/2025, 12/16/2025, 01/13/2026, and 01/20/2026 with gross proceeds ranging from about $48,987.43 to $128,242.01. The signer represents that they do not know of any undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the APLS Rule 144 filing disclose about upcoming share sales?

The filing discloses an intent to sell 7,832 shares of APLS common stock under Rule 144 through Fidelity Brokerage Services LLC, with an approximate sale date of 01/22/2026 on the NASDAQ.

How were the 7,832 APLS shares in the Rule 144 notice acquired?

The 7,832 APLS common shares were acquired on 01/21/2026 via restricted stock vesting from the issuer as compensation.

What is the reported market value of the APLS shares to be sold under Rule 144?

The Rule 144 notice reports an aggregate market value of $170,466.61 for the 7,832 APLS common shares to be sold.

How many APLS shares were outstanding according to this Rule 144 filing?

The filing states that 126,525,218 shares of APLS common stock were outstanding for the class referenced in the planned sale.

Who has recently sold APLS shares and what prior sales are listed?

The notice lists David O. Watson as seller of APLS common stock in several past 3‑month transactions, including 5,000 shares on 11/17/2025, 5,000 shares on 12/16/2025, 5,780 shares on 01/13/2026, and 2,475 shares on 01/20/2026.

What representation does the seller make about APLS in this Rule 144 notice?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Which broker and exchange are identified for the APLS Rule 144 sale?

The planned Rule 144 sale is through Fidelity Brokerage Services LLC, with the securities to be sold on the NASDAQ.
Apellis Pharmace

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Latest SEC Filings

APLS Stock Data

2.78B
106.56M
13.68%
105.74%
16.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM